MTOR and hepatocellular carcinoma: The AMPK activation by metformin enhances the binding of DEPTOR and mTOR by increasing DEPTOR production and inhibiting proteasomal degradation, thereby interfering with the downstream target p70-S6 kinase and ribosomal protein S6 and inhibiting the proliferation of hepatocellular carcinoma cells (75, 76).